Literature DB >> 18071871

Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor.

Hideki Takeshita1, Junji Yonese, Yasuhisa Fujii, Satoru Kawakami, Yoshinobu Komai, Yuhei Ohkubo, Shinya Yamamoto, Yuichi Ishikawa, Yasuyuki Seto, Shigekazu Ohyama, Iwao Fukui.   

Abstract

A 34 year-old man with a diagnosis of nonseminomatous testicular cancer with retroperitoneal lymph node metastasis (T1N3M0S2, stage IIIb; intermediate prognosis, made after right inguinal orchiectomy was performed) was referred to our hospital after having had a total of eight courses of systemic chemotherapy and external-beam radiotherapy to the retroperitoneal region in the previous 1 year. His serum alpha-fetoprotein (AFP) level remained elevated. Two courses of paclitaxel, etoposide, and cisplatin combined chemotherapy (TEP; paclitaxel 120 mg/m(2) day 1, etoposide 80 mg/m(2) days 2-5, cisplatin 20 mg/m(2) days 2-5) failed to normalize the AFP level. During the following 2 years he underwent salvage surgery four times; infrarenal retroperitoneal lymph node dissection (RPLND), left neck lymph node dissection, thoracic duct excision, and suprarenal RPLND. Viable cancer cells were found in all surgically resected specimens, except for the neck lymph node specimen. The serum AFP level was normalized and he has been well without relapse for 2 years after the last surgery. The present case suggests that repeated salvage surgery may be beneficial in selected patients with a chemotherapy-resistant metastatic germ cell tumor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071871     DOI: 10.1007/s10147-007-0686-6

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  4 in total

1.  Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.

Authors:  Stuart Hinton; Paul Catalano; Lawrence H Einhorn; Patrick J Loehrer; Timothy Kuzel; David Vaughn; George Wilding
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

2.  Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers.

Authors:  P Albers; A Ganz; E Hannig; W D Miersch; S C Müller
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

3.  Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.

Authors:  D P Wood; H W Herr; R J Motzer; V Reuter; P C Sogani; M J Morse; G J Bosl
Journal:  Cancer       Date:  1992-11-01       Impact factor: 6.860

4.  Surgical salvage of chemorefractory germ cell tumors.

Authors:  B R Murphy; E S Breeden; J P Donohue; J Messemer; W Walsh; B J Roth; L H Einhorn
Journal:  J Clin Oncol       Date:  1993-02       Impact factor: 44.544

  4 in total
  1 in total

1.  Successful long-term [corrected] remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic non-seminomatous [corrected] germ cell tumor: an additional report to Int J Clin Oncol 2007; 12:485-487.

Authors:  Hideki Takeshita; Junji Yonese; Iwao Fukui
Journal:  Int J Clin Oncol       Date:  2010-08-06       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.